<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01867268</url>
  </required_header>
  <id_info>
    <org_study_id>2137</org_study_id>
    <secondary_id>21843</secondary_id>
    <nct_id>NCT01867268</nct_id>
  </id_info>
  <brief_title>Effect of Acetazolamide &amp; Position in CSF Leakage and Collection and Wound Dehiscence</brief_title>
  <official_title>Evaluating the Effect of Acetazolamide Administration and Prone Positioning Following Lumbosacral Spinal Surgery in Preventing Cerebro Spinal Fluid Leakage and Collection and Wound Dehiscence in Children.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Tehran University of Medical Sciences</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Tehran University of Medical Sciences</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      -  Purpose of study : to determine the preventive effect of acetazolamide administration,
           prone positioning, and the combination of both following the neurosurgical interventions
           in lumbosacral region for cerebrospinal fluid (CSF) leak, CSF collection and wound
           dehiscence.

        -  Sample size: 144

        -  intervention groups:

             -  Group A: Acetazolamide administration for 10 days

             -  Group B: prone positioning for 10 days

             -  Group C: Acetazolamide administration and prone positioning for 10 days

             -  Group D: no intervention

        -  Period of study: Autumn 2012 to the end of winter of 2015
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The purpose of this study is to evaluate the effect of Acetazolamide administration and prone
      positioning following lumbosacral spinal surgery in preventing cerebro-spinal fluid leakage
      and collection and wound dehissence in children admitted to Children Medical Center of Tehran
      since Autumn 2012 to the end of winter of 2015.The study is run under 4 categories of
      intervention:

        -  Group A: Acetazolamide administration for 10 days

        -  Group B: prone positioning for 10 days

        -  Group C: Acetazolamide administration and prone positioning for 10 days

        -  Group D: no intervention All patients are randomly assigned to these groups and when the
           patients faced with any of these complications, the protocol changes to Acetazolamide
           administration and prone positioning and the patient is considered as the failure of the
           protocol.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>October 2012</start_date>
  <completion_date type="Anticipated">September 2015</completion_date>
  <primary_completion_date type="Anticipated">April 2015</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Factorial Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Cerebrospinal fluid leakage</measure>
    <time_frame>1month</time_frame>
    <description>leakage of CSF during 1 months following surgery</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Cerebrospinal fluid collection</measure>
    <time_frame>1 month</time_frame>
    <description>collection of the CSF beneath the skin during 1 month following the surgery</description>
  </primary_outcome>
  <primary_outcome>
    <measure>wound dehiscence</measure>
    <time_frame>1 month</time_frame>
    <description>dehiscence of the surgical wound during the first month following surgery</description>
  </primary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">144</enrollment>
  <condition>Fibrolipoma of Filum Terminale</condition>
  <condition>Lipomyelomeningocele</condition>
  <condition>Split Cord Malformation</condition>
  <condition>Dermal Sinus</condition>
  <condition>Tethered Cord Syndrome</condition>
  <condition>Tumor</condition>
  <arm_group>
    <arm_group_label>Acetazolamide</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>administration of Acetazolamide for 10 days following the surgery</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>control group without any intervention</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Prone positioning</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Positioning the patient following surgery for 10 days</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Acetazolamide and Prone positioning</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>applying both Acetazolamide and prone positioning</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Acetazolamide</intervention_name>
    <description>Acetazolamide administration for 10 days adjust dosage with weight of the patient</description>
    <arm_group_label>Acetazolamide</arm_group_label>
    <other_name>Diamox</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>prone positioning</intervention_name>
    <description>prone positioning the patient for 10 days following the surgery</description>
    <arm_group_label>Prone positioning</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Acetazolamide+ prone positioning</intervention_name>
    <description>administration of acetazolamide and position the patient for 10 days following the surgery</description>
    <arm_group_label>Acetazolamide and Prone positioning</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Untethering surgery for primary tethered cord caused by thick filum

          -  Lipomyelomeningocele

          -  Split cord malformation management

          -  Untethering surgery in uncomplicated Dermal sinus

          -  Tumors needing intradural management in lumbosacral region

          -  Having any other disease with similar management technique

        Exclusion Criteria:

          -  Infected dermoid tumors

          -  Intramedullary abscess

          -  Myelomeningocele surgery and related reoperation

          -  Meningocele

          -  Presence of hydrocephalus
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Farideh Nejat, MD</last_name>
    <role>Study Director</role>
    <affiliation>Tehran University of Medical Sciences</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Farideh Nejat, MD</last_name>
    <phone>+98 912 1494064</phone>
    <email>nejat@tums.ac.ir</email>
  </overall_contact>
  <location>
    <facility>
      <name>Children`S Medical Center</name>
      <address>
        <city>Tehran</city>
        <country>Iran, Islamic Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>+98 21 61479</phone>
    </contact>
    <investigator>
      <last_name>Shima Shahjouei, Student</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Iran, Islamic Republic of</country>
  </location_countries>
  <reference>
    <citation>Chern JJ, Tubbs RS, Patel AJ, Gordon AS, Bandt SK, Smyth MD, Jea A, Oakes WJ. Preventing cerebrospinal fluid leak following transection of a tight filum terminale. J Neurosurg Pediatr. 2011 Jul;8(1):35-8. doi: 10.3171/2011.4.PEDS10502.</citation>
    <PMID>21721886</PMID>
  </reference>
  <verification_date>April 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 29, 2013</study_first_submitted>
  <study_first_submitted_qc>May 31, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 3, 2013</study_first_posted>
  <last_update_submitted>April 17, 2015</last_update_submitted>
  <last_update_submitted_qc>April 17, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 21, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Acetazolamide administration</keyword>
  <keyword>prone positioning</keyword>
  <keyword>Cerebrospinal fluid leakage</keyword>
  <keyword>Cerebrospinal fluid collection</keyword>
  <keyword>wound dehiscence</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Congenital Abnormalities</mesh_term>
    <mesh_term>Neural Tube Defects</mesh_term>
    <mesh_term>Spina Bifida Occulta</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Acetazolamide</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

